Illumina ILMN
NASDAQ ILMN
$245.18 +16.25 (+7.10%)
At close: Sep 17, 2026 · 4:00 PM EDT

Illumina (ILMN) Asset Writedowns and Impairment (2012 - 2025)

Illumina's (ILMN) quarterly Asset Writedowns and Impairment came in at $23.0 million in Q2 2025, down 98.78% on a YoY basis from $1.9 billion in Q2 2024, and down 98.78% quarter-over-quarter from $1.9 billion in Q2 2024.

Analysis

Illumina (ILMN) Asset Writedowns and Impairment (2012 - 2025) Analysis & Trends

Illumina (ILMN) has reported Asset Writedowns and Impairment for 5 consecutive years, with $23.0 million the latest figure, recorded in Q2 2025.

  • For the quarter ending Q2 2025, Asset Writedowns and Impairment fell 98.78% year-over-year to $23.0 million; the trailing twelve-month figure through Dec 2025 stood at $23.0 million (down 98.78% YoY), and the FY2024 full-year result was $1.9 billion, up 128.42% from the prior year.
  • Asset Writedowns and Impairment slipped to $23.0 million in Q2 2025 per ILMN's latest filing, from $1.9 billion in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.9 billion in Q2 2024 and bottomed at $6.0 million in Q4 2023.
  • Historically, Asset Writedowns and Impairment has averaged $684.0 million across 3 years, with a median of $422.0 million in 2023.
  • The widest YoY moves for Asset Writedowns and Impairment: up 98.78% in 2025, down 98.78% in 2025.
  • Over 3 years, Asset Writedowns and Impairment stood at $6.0 million in 2023, then soared by 31333.33% to $1.9 billion in 2024, then tumbled by 98.78% to $23.0 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $23.0 million, $1.9 billion, and $6.0 million for Q2 2025, Q2 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 29, 2025 23.00 Mn
Jun 30, 2024 1.89 Bn
Dec 31, 2023 6.00 Mn
Oct 1, 2023 821.00 Mn
Apr 2, 2017 23.00 Mn
Jul 1, 2012 21.44 Mn